Ancestral Genomic Functional Differences in Oligodendroglia: Implications for Alzheimer’s Disease
Author Information
Author(s): Ramirez Aura M, Bertholim-Nasciben Luciana, Moura Sofia, Coombs Lauren E, Rajabli Farid, DeRosa Brooke A., Whitehead Patrice G, Adams Larry D, Starks Takiyah D, Mena Pedro, Illannes-Manrique Maryenela, Tejada Sergio J, Byrd Goldie S, Caban-Holt Allison, Cuccaro Michael, McInerney Katalina, Cornejo-Olivas Mario, Feliciano-Astacio Briseida, Wang Liyong, Robayo Maria C, Xu Wanying, Jin Fulai, Pericak-Vance Margaret A, Griswold Anthony J, Dykxhoorn Derek M, Young Juan I, Vance Jeffery M
Primary Institution: University of Miami Miller School of Medicine
Hypothesis
This study aims to elucidate ancestry-specific changes to the genomic regulatory architecture in induced pluripotent stem cell (iPSC)-derived oligodendroglia, focusing on their implications for Alzheimer’s disease (AD).
Conclusion
The research emphasizes the importance of including diverse ancestries in AD research to uncover critical gene expression differences that may influence disease susceptibility and therapeutic interventions.
Supporting Evidence
- The study generated 12 iPSC lines from diverse ancestries to analyze gene expression differences.
- Ancestry-specific differences in gene expression and chromatin accessibility were identified.
- APOE4/4 carriers showed significant upregulation of cholesterol biosynthesis genes across all ancestries.
- High correlation was found between iPSC-derived oligodendroglia and human brain transcriptomes.
- Findings support the relevance of using diverse ancestries in AD research.
- Cholesterol dysregulation in APOE4/4 carriers may have implications for early therapeutic interventions.
- Study highlights the necessity of addressing health disparities in Alzheimer's disease research.
- Results provide a resource for understanding genetic factors specific to certain populations.
Takeaway
Scientists studied brain cells from different ancestry groups to see how they might be affected by Alzheimer's disease, finding important differences that could help in treating the disease.
Methodology
The study generated 12 iPSC lines from different ancestries and analyzed them using RNA sequencing and ATAC sequencing to assess gene expression and chromatin accessibility.
Potential Biases
Potential bias due to the underrepresentation of certain ancestries in previous studies.
Limitations
The study's findings may be limited by the number of individuals included in the iPSC studies, which affects the representation of the population.
Participant Demographics
Participants included individuals from African, Amerindian, and European ancestries, with varying APOE genotypes.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website